1. Home
  2. VERU vs ACNT Comparison

VERU vs ACNT Comparison

Compare VERU & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • ACNT
  • Stock Information
  • Founded
  • VERU 1971
  • ACNT 1945
  • Country
  • VERU United States
  • ACNT United States
  • Employees
  • VERU N/A
  • ACNT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • ACNT Steel/Iron Ore
  • Sector
  • VERU Health Care
  • ACNT Industrials
  • Exchange
  • VERU Nasdaq
  • ACNT Nasdaq
  • Market Cap
  • VERU 108.8M
  • ACNT 109.8M
  • IPO Year
  • VERU 1990
  • ACNT N/A
  • Fundamental
  • Price
  • VERU $0.98
  • ACNT $11.09
  • Analyst Decision
  • VERU Strong Buy
  • ACNT
  • Analyst Count
  • VERU 4
  • ACNT 0
  • Target Price
  • VERU $4.00
  • ACNT N/A
  • AVG Volume (30 Days)
  • VERU 2.2M
  • ACNT 32.1K
  • Earning Date
  • VERU 02-06-2025
  • ACNT 11-12-2024
  • Dividend Yield
  • VERU N/A
  • ACNT N/A
  • EPS Growth
  • VERU N/A
  • ACNT N/A
  • EPS
  • VERU N/A
  • ACNT N/A
  • Revenue
  • VERU $16,886,419.00
  • ACNT $178,417,000.00
  • Revenue This Year
  • VERU N/A
  • ACNT $5.81
  • Revenue Next Year
  • VERU N/A
  • ACNT $6.79
  • P/E Ratio
  • VERU N/A
  • ACNT N/A
  • Revenue Growth
  • VERU 3.62
  • ACNT 6.56
  • 52 Week Low
  • VERU $0.36
  • ACNT $8.16
  • 52 Week High
  • VERU $1.92
  • ACNT $12.38
  • Technical
  • Relative Strength Index (RSI)
  • VERU 74.65
  • ACNT 46.22
  • Support Level
  • VERU $0.70
  • ACNT $11.08
  • Resistance Level
  • VERU $0.81
  • ACNT $11.33
  • Average True Range (ATR)
  • VERU 0.11
  • ACNT 0.23
  • MACD
  • VERU 0.02
  • ACNT -0.07
  • Stochastic Oscillator
  • VERU 95.26
  • ACNT 4.69

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About ACNT Ascent Industries Co.

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Ascent Tubular Products and the Specialty Chemicals Segment. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive and commercial transportation, brewery, chemical, petrochemical and other industries. The Specialty Chemicals segment produces specialty products for the pulp and paper, coatings, adhesives, sealants and elastomers (CASE), textile, automotive, household and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

Share on Social Networks: